Press Releases

Low measure rates and minimal opportunity for improvement informed retirement vote

Independent pharmacists who participate will have access to InStep Health’s proven in-store marketing displays, product samples, and educational materials.

PBMs represent a “staggering national problem”

A patch pump with a larger, 300-unit (u) insulin reservoir could provide longer wear times and fewer disposable patches over time.

Company Named Best Overall Branded Pharmaceutical Product Manufacturer in its Sales Category for Fourth Consecutive Year

PBMs are Leeches: First video spot explains pharmacy benefit managers' role in higher drug prices.

The awards were announced last night at the ABA gala held at the Marriott Marquis in New York City.

Registration opens today, June 5, for the National Community Pharmacists Association’s 2024 Annual Convention, set for Oct. 26-29 in Columbus, Ohio.

Analysis Will Study Effects of IRA Provisions to Improve Access to Basal Insulin

Almost half of independent pharmacy owners/managers participating in an NCPA survey said that ESI was the pharmacy benefit manager causing the most financial stress in Medicare Part D.

Courtney B. Smith, PharmD, CSP, BCMTMS has been awarded a prestigious 2024 NASPA Excellence in Innovation Award.

As part of the Dr. Reddy’s senior leadership team, he will be responsible for the company’s North America business and will be based out of the Princeton, New Jersey, U.S. office.

Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)

Rufinamide Oral Suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults.

Pagniano’s responsibilities will include leading the foundation’s strategic growth.

Camber Pharmaceuticals is thrilled to announce the addition of Aripiprazole Oral Solution to its product line, complementing the existing product family that included Aripiprazole Tablets.

The partnership aims to accelerate innovation in drug discovery by increasing success rates and reducing timelines through screening a billion+ small-molecule compounds either in a living cell or on a purified drug target protein.

In September 2022, Bayer launched the patented drug vericiguat under the brand name Verquvo™ in India.

Camber Pharmaceuticals is pleased to announce the addition of Levonorgestrel and Ethinyl Estradiol Tablets USP to its current portfolio.

Aurigene.AI is an end-to-end solution for small molecule drug discovery combining AI and ML capabilities with Aurigene's core expertise in synthesizing and testing the molecules in vitro and in vivo.

Camber Pharmaceuticals is pleased to announce the addition of Allopurinol Tablets, USP to its current portfolio.

Alabama Pharmacist Recognized for Advancing the Profession of Pharmacy